Article · 16 Sep 2026
Conference abstract
Tanshinone IIA with Synergic Effects for 5-FU to Treat Human Colon Cancer colo 205 cells Xerograft Tumour
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Tanshinone IIA (Tan-IIA) was one of the diterpene quinone in Danshen, Salviae miltiorrhizae Radix. Tan-IIA could inhibit human colon cancer colo 205 cells in vitro and in vivo through decreasing ErbB2 and increasing TNF-α expression. But the synergic effects for Tan-IIA and 5-fluorouracil (5-FU) were not well evaluated .In the present study, the 3 weeks old, male; mice (NOD.CB17 prkdescid/TZU, number=24 ) were engrafted with human colon cancer colo205 cells and on day 10 onwards were divided into three groups .Each group were treated with vehicle alone, 5-FU(20mg/ kg, I.P, QW1) and 5-FU(20mg/kg, I.P, QW1) plus Tan-IIA (20mg/kg, I.P, QW3,5) respectively. The xenografted tumor volumes were measured every other day. At the end of 4-weeks dosing schedule, the mice were sacrificed with CO2 inhalation and colo 205 xenografted tumors were dissected and weighted, and then extracted total protein for proteomics 2D LC/MS analysis and western blot analysis. The results showed that the 5-FU plus Tan-IIA group resulted in a reduction in tumors volume and weight compared to the 5-FU group. The molecular mechanisms may be through down regulating P-Gp, LC3-II, MMP-2, MMP-7, VEGF, Topoisomerase I and Erb-B2 proteins expression. The proteomics 2D and LC/MS analysis showed that the proteins expression in 5-FU plus Tan-IIA group were up regulated more than double times when compared to 5-FU group including heterogeneous nuclear ribonucleoprotein H1,H2/ NCK-associated protein 1, isoform CRA, Porin 31HM/ voltage-dependent anion channel 1; down regulated more than 50% including as follow :peroxiredoxin 1/Porin 31HM/voltage-dependent anion channel 1/peroxiredoxin 4/enolase 1.
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutica Analytica Acta.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Chin-Cheng Su”
